Treating diabetes with aerosolized insulin

Chest

Volumn 120, Issue 3 SUPPL., 2001, Pages 99S-106S

  Laube, B L ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Aerosol; Diabetes; Insulin; Intrapulmonary delivery

Indexed keywords

INSULIN; PEPTIDE DERIVATIVE;

AEROSOL; ANALGESIA; CLINICAL TRIAL; DIABETES CONTROL; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; LUNG FUNCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

EID: 0034826771     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.120.3_suppl.99S     Document Type: Article

References (34)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
2. Uber inhalation von insulin
3. Upper airway: Structure, function and therapy
4. Morphometrics of the lung
5. Prediction of drug residence times in regions of the human respiratory tract following aerosol inhalation
6. Insulin administered intranasally as an insulin-bile salt aerosol: Effectiveness and reproducibility in normal and diabetic subjects
7. Intranasal aerosolized insulin: Mixed-meal studies and long-term use in type I diabetes
8. Ultrastructural features of alveolar epithelial transport
9. Number and distribution of plasmalemmal vesicles in the lung
10. Parenteral absorption of insulin from the lung in diabetic children
11. Insulin across respiratory mucosae by aerosol delivery
12. Aerosol salbutamol administration by IPPB: Lowest effective dose
13. A high frequency ultrasonic nebulizer system for radioaerosol delivery
14. Distal penetration in radioaerosol inhalation with an ultrasonic nebulizer
15. Preliminary study of the efficacy of insulin aerosol delivered by oral inhalation in diabetic patients
16. The lung as an alternative route of delivery for insulin in controlling postprandial glucose levels in patients with diabetes
17. Drug therapy: The physiologic replacement of insulin
18. Intrapulmonary administration of insulin to healthy volunteers
19. Nicht radioactives verfahren zur messung der lungenpermeabilitat: Inhalation von insulin
20. Factors influencing the absorption, serum insulin concentration and blood glucose responses after injections of regular insulin and various insulin mixtures
21. Time-action profile of inhaled insulin
22. Insulin administration via the AeroDose™ inhaler: Comparison to subcutaneously injected insulin
23. Effects of intrapulmonary insulin in patients with non-insulin-dependent diabetes
24. Time to peak insulin level, relative bioavailability and effect of site of deposition of nebulized insulin in patients with non-insulin-dependent diabetes mellitus
25. Aerosol insulin: A brief review
26. Issues in pulmonary delivery
27. Treatment of type I diabetes mellitus with inhaled human insulin: A 3-month, multicenter trial
28. Treatment of type II diabetes mellitus with inhaled human insulin: A 3-month, multicenter trial
29. Adjunctive therapy with inhaled human insulin in type II diabetic patients failing oral agents: A multicenter phase II trial
30. Chronic insulin injection in five successive generations of white rats: Report of gross and histological findings
31. Suppression of IgE responses following inhalation of antigen: A natural homeostatic mechanism, which limits sensitization of aeroallergens
32. Deep-lung delivery of therapeutic proteins
33. x™
34. In vivo measurements of aerosol dose and distribution: Clinical relevance